Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 1.83
(4.87%)
AUD 1.83
(4.87%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 154.62 Million AUD | 101.09% |
| 2023 | 76.89 Million AUD | -22.97% |
| 2022 | 99.82 Million AUD | 341.44% |
| 2021 | 22.61 Million AUD | 148.08% |
| 2020 | 9.11 Million AUD | -12.04% |
| 2019 | 10.36 Million AUD | 271.88% |
| 2018 | 2.78 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 154.62 Million AUD | 165.81% |
| 2024 Q1 | 58.17 Million AUD | -41.72% |
| 2024 FY | 154.62 Million AUD | 101.09% |
| 2024 Q4 | 154.62 Million AUD | 0.0% |
| 2024 Q2 | 58.17 Million AUD | 0.0% |
| 2023 FY | 76.89 Million AUD | -22.97% |
| 2023 Q4 | 99.82 Million AUD | 29.81% |
| 2023 Q3 | 76.89 Million AUD | -14.27% |
| 2023 Q2 | 89.69 Million AUD | 0.0% |
| 2023 Q1 | 89.69 Million AUD | -10.14% |
| 2022 Q2 | 103.76 Million AUD | 0.0% |
| 2022 Q1 | 103.76 Million AUD | 358.88% |
| 2022 FY | 99.82 Million AUD | 341.44% |
| 2022 Q4 | 99.82 Million AUD | 0.0% |
| 2022 Q3 | 99.82 Million AUD | -3.8% |
| 2021 Q4 | 22.61 Million AUD | 0.0% |
| 2021 Q1 | 26.69 Million AUD | 192.83% |
| 2021 FY | 22.61 Million AUD | 148.08% |
| 2021 Q2 | 113.47 Million AUD | 325.13% |
| 2021 Q3 | 22.61 Million AUD | -80.07% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 FY | 9.11 Million AUD | -12.04% |
| 2020 Q3 | 9.11 Million AUD | 0.0% |
| 2020 Q4 | 9.11 Million AUD | 0.0% |
| 2019 FY | 10.36 Million AUD | 271.88% |
| 2018 FY | 2.78 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -2674.613% |
| Acrux Limited | 8.96 Million AUD | -1625.195% |
| Race Oncology Limited | 20.22 Million AUD | -664.41% |
| Biome Australia Limited | 8.27 Million AUD | -1768.227% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | -37.491% |
| BTC Health Limited | 5.14 Million AUD | -2903.205% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -912.425% |
| CSL Limited | 56.93 Billion AUD | 99.728% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 33.097% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -505.155% |
| Hexima Limited | 2.26 Million AUD | -6714.849% |
| Immutep Limited | 147.44 Million AUD | -4.87% |
| Memphasys Limited | 12.43 Million AUD | -1143.985% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 37.642% |
| Noxopharm Limited | 6.78 Million AUD | -2179.403% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -658.252% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | -114.654% |
| Starpharma Holdings Limited | 36.81 Million AUD | -320.028% |
| Tissue Repair Ltd | 19.38 Million AUD | -697.486% |
| Biotron Limited | 493.47 Thousand AUD | -31234.697% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -704.366% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -9151.356% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -4793.964% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -2883.152% |
| Patrys Limited | 4.16 Million AUD | -3615.637% |
| Orthocell Limited | 26.61 Million AUD | -480.981% |
| Imugene Limited | 151.39 Million AUD | -2.134% |
| PYC Therapeutics Limited | 91.23 Million AUD | -69.477% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -1321.863% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -1743.394% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -1063.966% |
| Nanollose Limited | 241.95 Thousand AUD | -63809.307% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -2426.6% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -2744.607% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -941.617% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -5929.673% |
| Nyrada Inc. | 5.9 Million AUD | -2517.612% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 61.178% |
| Dimerix Limited | 32.07 Million AUD | -382.033% |
| PharmAust Limited | 11.12 Million AUD | -1289.944% |
| AnteoTech Limited | 9.38 Million AUD | -1548.292% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -464.537% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -2327.607% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -2012.62% |
| Actinogen Medical Limited | 21.31 Million AUD | -625.554% |
| Immuron Limited | 15.54 Million AUD | -894.402% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -844.153% |